Addus HomeCare Co. (NASDAQ:ADUS) Shares Sold by Cambiar Investors LLC

Cambiar Investors LLC reduced its stake in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 7.9% during the 4th quarter, Holdings Channel.com reports. The fund owned 15,413 shares of the company’s stock after selling 1,320 shares during the quarter. Cambiar Investors LLC’s holdings in Addus HomeCare were worth $1,932,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Quarry LP purchased a new position in shares of Addus HomeCare during the third quarter worth approximately $28,000. Farther Finance Advisors LLC boosted its stake in Addus HomeCare by 9,150.0% during the 3rd quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock worth $49,000 after purchasing an additional 366 shares during the period. KBC Group NV grew its position in Addus HomeCare by 49.1% during the 4th quarter. KBC Group NV now owns 814 shares of the company’s stock worth $102,000 after purchasing an additional 268 shares during the last quarter. Assetmark Inc. increased its stake in Addus HomeCare by 11.5% in the third quarter. Assetmark Inc. now owns 1,169 shares of the company’s stock valued at $156,000 after purchasing an additional 121 shares during the period. Finally, GAMMA Investing LLC raised its holdings in shares of Addus HomeCare by 34.5% in the fourth quarter. GAMMA Investing LLC now owns 1,258 shares of the company’s stock valued at $158,000 after buying an additional 323 shares during the last quarter. 95.35% of the stock is owned by hedge funds and other institutional investors.

Addus HomeCare Stock Performance

Shares of NASDAQ ADUS opened at $114.67 on Wednesday. The company’s fifty day moving average is $126.47 and its two-hundred day moving average is $127.28. The firm has a market capitalization of $2.08 billion, a P/E ratio of 26.24, a PEG ratio of 1.55 and a beta of 1.00. Addus HomeCare Co. has a one year low of $85.94 and a one year high of $136.72.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on the company. JMP Securities started coverage on Addus HomeCare in a report on Monday, December 16th. They set an “outperform” rating and a $150.00 price target on the stock. Stephens boosted their target price on Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a report on Wednesday, November 6th. Royal Bank of Canada restated an “outperform” rating and set a $136.00 price target on shares of Addus HomeCare in a research note on Thursday, November 14th. Macquarie reiterated an “outperform” rating and issued a $139.00 price objective on shares of Addus HomeCare in a research report on Monday, November 4th. Finally, Oppenheimer upped their price objective on shares of Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. One investment analyst has rated the stock with a sell rating, eight have assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of “Buy” and an average price target of $134.22.

Insider Buying and Selling

In other news, EVP Roberton James Stevenson sold 2,250 shares of the firm’s stock in a transaction on Monday, December 9th. The stock was sold at an average price of $121.00, for a total value of $272,250.00. Following the completion of the transaction, the executive vice president now owns 10,217 shares in the company, valued at $1,236,257. This trade represents a 18.05 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO R Dirk Allison sold 25,000 shares of the business’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the completion of the sale, the chief executive officer now owns 79,397 shares in the company, valued at $9,905,569.72. This represents a 23.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 39,750 shares of company stock valued at $4,930,750. Corporate insiders own 4.60% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.